EMERGENT BIOSOLUTIONS INC. (EBS) Provides Business Update
EMERGENT BIOSOLUTIONS INC. (EBS) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: 7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U. 7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services to supply ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) vaccine, ancillaries as well as diluent replacement lots for smallpox preparedness and response needs. Deliveries are expected to begin this month.
Key Elements Identified:
Drugs/Compounds: modification, mpox, Million
Organizations: NYSE, the Saudi Food and Drug Authority, the United States Department of Health and Human Services
📋 EMERGENT BIOSOLUTIONS INC. (EBS) - Other Event
Filing Date: 2026-06-29
Accepted: 2026-06-29 11:14:38
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: 7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U. 7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services to supply ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) vaccine, ancillaries as well as diluent replacement lots for smallpox preparedness and response needs. Deliveries are expected to begin this month.
Key Elements Identified:
💼 Business Developments:
Structured Data: